CCP
KURA icon

Clough Capital Partners’s Kura Oncology KURA Stock Holding History

Clough Capital Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,361
Closed -$529K – 134
2021
Q2 		$529K Hold
25,361
– – 0.03% 118
2021
Q1 		$717K Hold
25,361
– – 0.03% 118
2020
Q4 		$828K Sell
25,361
-25,300
-50% -$889K 0.06% 107
2020
Q3 		$1.55M Sell
50,661
-16,900
-25% -$373K 0.11% 86
2020
Q2 		$1.1M Hold
67,561
– – 0.11% 99
2020
Q1 		$672K Sell
67,561
-3,100
-4% -$35.5K 0.07% 86
2019
Q4 		$972K Sell
70,661
-2,000
-3% -$29.6K 0.08% 87
2019
Q3 		$1.1M Sell
72,661
-3,800
-5% -$67.6K 0.09% 78
2019
Q2 		$1.51M Sell
76,461
-3,800
-5% -$63.1K 0.15% 79
2019
Q1 		$1.33M Hold
80,261
– – 0.12% 90
2018
Q4 		$1.13M Hold
80,261
– – 0.13% 97
2018
Q3 		$1.41M Sell
80,261
-46,100
-36% -$884K 0.13% 81
2018
Q2 		$2.3M Sell
126,361
-42,100
-25% -$713K 0.21% 76
2018
Q1 		$3.16M Sell
168,461
-44,300
-21% -$862K 0.3% 74
2017
Q4 		$3.25M Sell
212,761
-12,100
-5% -$178K 0.27% 71
2017
Q3 		$3.36M Sell
224,861
-196,136
-47% -$1.84M 0.23% 76
2017
Q2 		$3.92M Sell
420,997
-79,700
-16% -$726K 0.27% 76
2017
Q1 		$4.41M Sell
500,697
-159,392
-24% -$1.17M 0.28% 76
2016
Q4 		$3.9M Sell
660,089
-10,770
-2% -$57.7K 0.26% 89
2016
Q3 		$4.19M Sell
670,859
-77,180
-10% -$391K 0.22% 110
2016
Q2 		$2.03M Sell
748,039
-319,094
-30% -$992K 0.11% 132
2016
Q1 		$4.32M Sell
1,067,133
-20,100
-2% -$95.4K 0.2% 114
2015
Q4 		$9.13M Buy
+1,087,233
New +$8.56M 0.43% 76

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Clough Capital Partners's KURA Position: Q3 2021 in Review

Clough Capital Partners sold out of Kura Oncology (KURA) in Q3 2021, closing a stake of 25,361 shares — an estimated $529K sold.

Clough Capital Partners first reported a position in KURA in Q4 2015 and held it in 23 quarters. The position peaked at $9.13M in Q4 2015. 152 funds tracked by Wall St. Rank hold KURA as of Q3 2021.

  • Clough Capital Partners reported no remaining Kura Oncology position as of Q3 2021 after selling out during the quarter.
  • Clough Capital Partners sold 25,361 Kura Oncology shares in Q3 2021, an estimated $529K.
  • Clough Capital Partners first reported a position in Kura Oncology in Q4 2015 and held it in 23 quarters.
  • Clough Capital Partners's Kura Oncology position peaked at $9.13M in Q4 2015.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2021.

Based on Clough Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.